Clinical Outcomes after Upfront Surgery in Clinical Stage I–IIA Small Cell Lung Cancer
Background: Upfront surgery followed by systemic treatment is recommended to treat clinical stage I–IIA small cell lung cancer (SCLC), but data on the clinical outcomes are sparse. Thus, this study evaluated the stage migration and long-term prognosis of surgically treated clinical stage I–IIA SC...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Thoracic & Cardiovascular Surgery
2022-12-01
|
Series: | Journal of Chest Surgery |
Subjects: |